Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients
Journal article published in 2021 by
Natalia Ruetalo,
Ramona Businger,
Karina Althaus,
Simon Fink 
,
Felix Ruoff ,
Michaela Pogoda,
Angelika Iftner,
Tina Ganzenmüller,
Klaus Hamprecht,
Bertram Flehmig,
Tamam Bakchoul,
Markus F. Templin,
Michael Schindler
,
Felix Ruoff ,
Michaela Pogoda,
Angelika Iftner,
Tina Ganzenmüller,
Klaus Hamprecht,
Bertram Flehmig,
Tamam Bakchoul,
Markus F. Templin,
Michael Schindler
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
There is strong interest in the nature of the neutralizing antibody response against SARS-CoV-2 in infected individuals. For vaccine development, it is especially important which antibodies confer protection against SARS-CoV-2, if there is a phenomenon called antibody-dependent enhancement (ADE) of infection, and if there is cross-protection by antibodies directed against seasonal coronaviruses.